Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions

Completed

Conditions studied: High Grade Anal Canal Squamous Intraepithelial Neoplasia, Human Immunodeficiency Virus

In brief

This trial develops a health-related symptom index for participants with and either treated or monitored for anal high-grade squamous intraepithelial lesions. The health-related quality of life index may help to capture the symptoms and related experiences of living with or being treated for high-grade squamous intraepithelial lesions.

Key facts

Study ID

NCT04276935

Run by

AIDS Malignancy Consortium

People needed

20

Starts

2018-11-06

Expected to finish

2020-03-01

Last updated by the study team

2025-03-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Human immunodeficiency virus (HIV)-1 infection.
• Biopsy-proven anal HSIL within the prior nine months.
• Participant must have received anal HSIL treatment in the last nine months. If the participant's treatment plan is observation? the participant must have been diagnosed with anal HSIL in the last nine months.
• Life expectancy of greater than 5 years.
• Fluent in Spanish with limited English proficiency, per self-report.

You may not qualify if…

• History of anal cancer.
• Inability to understand a written consent form.

Where it is running

• University of California - San Francisco — San Francisco, California, United States
• Jackson Memorial Hospital — Miami, Florida, United States
• Anal Dysplasia Clinic MidWest — Chicago, Illinois, United States
• Virginia Mason Medical Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.